Sitagliptin is an oral antihyperglycemic (antidiabetic drug) of the dipeptidyl
peptidase-4 (DPP-4) inhibitor class. It was developed, and is marketed, by Merck
Easy to read patient leaflet for sitagliptin. Includes indications, proper use, special
instructions, precautions, and possible side effects.
Sitagliptin is used along with diet and exercise and sometimes with other
medications to lower blood sugar levels in patients with type 2 diabetes (
condition in ...
Learn about the prescription medication Januvia (Sitagliptin Phosphate), drug
uses, dosage, side effects, drug interactions, warnings, reviews and patient ...
Get information on JANUVIA® (sitagliptin) tablets and information to help
manage type 2 diabetes from the official Web site for JANUVIA.
Find patient medical information for sitagliptin oral on WebMD including its uses,
side effects and safety, interactions, pictures, warnings and user ratings.
May 16, 2007 ... Description. Sitagliptin is a new oral hypoglycemic (anti-diabetic drug) of the new
dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs.
Dec 24, 2014 ... Read about Januvia (sitagliptin), the diabetes medication that reduces blood
sugar levels in individuals with type 2 diabetes.
Januvia 25 mg film-coated tablets. 2. QUALITATIVE AND QUANTITATIVE
COMPOSITION. Each tablet contains sitagliptin phosphate monohydrate,
equivalent to ...
Mar 14, 2016 ... However, because sitagliptin is primarily renally eliminated, severe hepatic
impairment is not expected to affect the pharmacokinetics of ...